2020 Jun 23 - Knowledge Resource Series #3 Biomarker Development Webinar
Christopher Bunker, Ph.D., MBA
Senior Director, Business Development, Advanced Cell Diagnostics
Watch Video:

RNAscope in situ hybridization (ISH) platforms are utilized widely for high resolution tissue-based and cell-specific analysis of targets and biomarkers.  

ACD’s RNAscope ISH platform is clinically validated and enable quantitative expression analysis that has proven repeatedly to better stratify treatment-responsive and non-responsive patients in novel therapeutic clinical trials compared to more established methods, like IHC and qPCR. 

RNAscope is often more sensitive than IHC and provides cell-specific biomarker data in complex tissue microenvironments that qPCR cannot. 

A further advantage is speed. RNAscope biomarker assays can be verified and ready for use on clinical biopsies in a matter of weeks.

Learning Objectives:
  • Quantifiable, single-molecule detection of biomarker RNA in fixed biopsies
  • Superior performance against established methods, e.g., IHC, qPCR
  • Multiplexed analysis for immuno-oncology biomarkers
  • Application in small molecule, biologic and cell therapy biomarkers


Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798



19 Barton Lane  
Abingdon Science Park
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420


Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com